SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-134413
Filing Date
2016-11-14
Accepted
2016-11-14 17:42:06
Documents
74
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v450603_10q.htm 10-Q 582012
2 EXHIBIT 31.1 v450603_ex31-1.htm EX-31.1 9067
3 EXHIBIT 31.2 v450603_ex31-2.htm EX-31.2 8906
4 EXHIBIT 32.1 v450603_ex32-1.htm EX-32.1 4869
  Complete submission text file 0001144204-16-134413.txt   5277472

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20160930.xml EX-101.INS 1151558
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20160930.xsd EX-101.SCH 61812
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20160930_cal.xml EX-101.CAL 50617
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20160930_def.xml EX-101.DEF 341206
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20160930_lab.xml EX-101.LAB 433992
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20160930_pre.xml EX-101.PRE 389449
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 161996571
SIC: 2834 Pharmaceutical Preparations